Figures & data
Figure 3. Several modifications of AuNPs. (A) Change the shape of the AuNPs to become gold nanostars and gold nanorods. (B) Change the diameter of the AuNPs to make them different in size. (C) Zwitterionic surface engineering of AuNPs. (D) PEGlyation with surface of AuNPs. (E) Different surface charge of AuNPs.
![Figure 3. Several modifications of AuNPs. (A) Change the shape of the AuNPs to become gold nanostars and gold nanorods. (B) Change the diameter of the AuNPs to make them different in size. (C) Zwitterionic surface engineering of AuNPs. (D) PEGlyation with surface of AuNPs. (E) Different surface charge of AuNPs.](/cms/asset/6c4a909a-a2bc-4e0d-a613-daa81064ee79/ianb_a_1687501_f0003_c.jpg)
Figure 4. Delivery process of optimized gold nanocarriers in vivo. (a) Two types of optimized gold nanocarriers with drugs. (b) Ideal delivery process of optimized gold nanocarriers with drugs in vivo: prolonged blood circulation, enhancement of targeting accumulation, improvement of cellular uptake and control of intracellular release.
![Figure 4. Delivery process of optimized gold nanocarriers in vivo. (a) Two types of optimized gold nanocarriers with drugs. (b) Ideal delivery process of optimized gold nanocarriers with drugs in vivo: prolonged blood circulation, enhancement of targeting accumulation, improvement of cellular uptake and control of intracellular release.](/cms/asset/ac8639e7-cf7a-4d91-9f5d-51d0c0220435/ianb_a_1687501_f0004_c.jpg)